Latest News Archive
Please select Category, Year, and then Month to display items
07 March 2018
Photo Supplied
Ts’epang Sello, one of the Kovsie contenders for a medal at Friday’s Varsity athletics meeting.
Ts’epang Sello, one of the Kovsie contenders
for a medal at Friday’s Varsity athletics meeting.
Photo: Supplied
The University of the Free State will hope to start developing their next Wayde van Niekerk when the first Varsity athletics meeting takes place on Friday at the Tuks Athletics Stadium in Pretoria.
The second meeting is on 23 March, also in Pretoria.
Thirteen members (five men and eight women) of the Kovsie team of 25 are still under the age of 21.
The hope for medals among the men would be on Sefako Mokhosoa (triple jump), Hendrik Maartens, and Tsebo Matsoso (both 200 m). Mokhosoa, who represented South Africa last year at the Southern Region Championships, is in red-hot form and achieved a personal best of 16.13 m at the Motheo/Xhariep meeting two weeks ago. This is currently the third best distance in the country for 2018.
Maartens would like to go one step further. In last year’s final Varsity meeting, he finished second in 20.62. Great things are expected of Matsoso, a first-year student who competed at the African Junior Championship in 2017. Last year, he was one of the top athletes at school level by winning the SA title in a time of 21.14.
Ts’epang Sello (800 m) and Elmé Smith (100 m and 200 m) will lead the charge for the women. Sello already came close to her personal best (2:09.8) this year, while Smith has also been running fast times. Her best this year was 11.88 (100 m) and 24.53 (200 m).
Tyler Beling (1 500 m) is another first-year student who is showing great potential. She obtained a fourth position at last weekend’s CAA Southern Region Cross-country Championships. Maryke Brits (100 m hurdles and long jump) is a possible medallist, despite running her first event for the year on Wednesday night.
The meeting starts at 17:15 and will be broadcast on SuperSport 5.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”